MedPath

Baxter Holding BV

🇳🇱Netherlands
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

CIMA_AEMPS:14
EMA:4
NMPA:3

Drug Approvals

Hemofiltration Replacement Fluid of Sodium Bicarbonate

Product Name
碳酸氢钠血滤置换液
Approval Number
国药准字HJ20220049
Approval Date
May 18, 2022
NMPA

Hemofiltration Replacement Fluid of Sodium Bicarbonate and Phosphate

Product Name
磷/碳酸氢钠血滤置换液
Approval Number
国药准字HJ20220016
Approval Date
Mar 8, 2022
NMPA

Hemofiltration Replacement Fluid of Sodium Citrate

Product Name
枸橼酸钠血滤置换液
Approval Number
国药准字HJ20210035
Approval Date
May 19, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.